فضلا اضغط بالاسفل
يستعمل دواء فيمارا 2.5 مجم 30 قرصfemara 2.5mg 30 f.c.tabs. non-steroidal aromatase inhibitor non-steroidal aromatase inhibitor
about letrozole -non-steroidal aromatase inhibitor antineoplastic. - -mechanism of action of letrozole -this aromatase enzyme inhibitor competitively and reversibly bind to the heme portion of cytochrome p450 unit of aromatase enzyme (which convert the androgens to estrogens) and inhibit its activity. -it causes the reduction in plasma estrogen level and then the growth of estrogen related tumors growth. - -indications for letrozole -1. breast cancer especially in post menopausal woman. -2. pre-operative treatment in post-menopausal women with localized hormone-receptor-positive breast cancer. -typical dosage for letrozole -oral- -adult- -2.5mg once daily. - -contra-indications of letrozole -1. hypersensitivity to the drug and its components -2. severe hepatic impairment -3. premenopausal woman
تركيبة دواءفيمارا 2.5 مجم 30 قرصfemara 2.5mg 30 f.c.tabs.
يتركب هذا الدواء من :letrozole
الشركة المنتجة لدواءفيمارا 2.5 مجم 30 قرصfemara 2.5mg 30 f.c.tabs.
هذا الدواء من انتاج شركة novartis
جرعة دواءفيمارا 2.5 مجم 30 قرص
Welcome to Dlildwa, specifically the page of femara 2.5mg 30 f.c.tabs..
تم استعراض بدائل هذا الدواء 2237 مرة